Harmony Biosciences Holdings, Inc.
HRMY
$38.05
$0.882.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.53% | -8.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.53% | -8.21% | |||
| Cost of Revenue | 19.25% | -41.20% | |||
| Gross Profit | 6.28% | 4.00% | |||
| SG&A Expenses | 3.30% | 9.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.54% | -11.72% | |||
| Operating Income | -14.34% | 0.93% | |||
| Income Before Tax | -13.19% | 1.82% | |||
| Income Tax Expenses | -15.12% | 73.91% | |||
| Earnings from Continuing Operations | -12.70% | -7.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.70% | -7.91% | |||
| EBIT | -14.34% | 0.93% | |||
| EBITDA | -12.97% | 0.84% | |||
| EPS Basic | -12.94% | -8.25% | |||
| Normalized Basic EPS | -13.44% | 1.45% | |||
| EPS Diluted | -12.82% | -8.04% | |||
| Normalized Diluted EPS | -13.04% | 1.28% | |||
| Average Basic Shares Outstanding | 0.28% | 0.37% | |||
| Average Diluted Shares Outstanding | -0.17% | 0.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||